Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.
about
Overcoming Challenges With Statin TherapyThe role of Fatty Acid oxidation in the metabolic reprograming of activated t-cellsLongitudinal Metabolomic Profiling of Amino Acids and Lipids across Healthy PregnancyAssessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney diseaseLong-term effects of oral L-carnitine supplementation on anemia in chronic hemodialysis.Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic studyThe Roles of Reactive Oxygen Species and Nitric Oxide in Perfluorooctanoic Acid-Induced Developmental Cardiotoxicity and l-Carnitine Mediated Protection.The effect of homozygous deletion of the BBOX1 and Fibin genes on carnitine level and acyl carnitine profile.Exploration of lipid metabolism in relation with plasma membrane properties of Duchenne muscular dystrophy cells: influence of L-carnitineFish oil and the pan-PPAR agonist tetradecylthioacetic acid affect the amino acid and carnitine metabolism in rats.The functions of cardiolipin in cellular metabolism-potential modifiers of the Barth syndrome phenotypeUrine L-carnitine excretion in hypertensive adolescentsCarnitine levels in skeletal muscle, blood, and urine in patients with primary carnitine deficiency during intermission of L-carnitine supplementationNickel inhibits mitochondrial fatty acid oxidation.Long-chain Acylcarnitines Reduce Lung Function by Inhibiting Pulmonary Surfactant.Krill oil reduces plasma triacylglycerol level and improves related lipoprotein particle concentration, fatty acid composition and redox status in healthy young adults - a pilot study.The Effect of Copper And Zinc Nanoparticles on the Growth Parameters, Contents of Ascorbic Acid, and Qualitative Composition of Amino Acids and Acylcarnitines in Pistia stratiotes L. (Araceae).CYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid.Plasma acylcarnitines and risk of cardiovascular disease: effect of Mediterranean diet interventions.Acylcarnitines--old actors auditioning for new roles in metabolic physiology.Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure.Efficacy of a novel formulation of L-Carnitine, creatine, and leucine on lean body mass and functional muscle strength in healthy older adults: a randomized, double-blind placebo-controlled study.Environmental Enteric Dysfunction is Associated with Carnitine Deficiency and Altered Fatty Acid Oxidation.Serum Acylcarnitines and Risk of Cardiovascular Death and Acute Myocardial Infarction in Patients With Stable Angina PectorisComparative metabolomics profiling of isogenic KRAS wild type and mutant NSCLC cells in vitro and in vivo.The effects of oral L-carnitine supplementation on physical capacity and lipid metabolism in chronic hemodialysis patients.Hemodynamic stabilizing effects of L-carnitine in chronic hemodialysis patients.L-Carnitine supplementation to reverse hyperammonemia in a patient undergoing chronic valproic acid treatment: A case report.Carnitine and/or Acetylcarnitine Deficiency as a Cause of Higher Levels of AmmoniaMitochondrial Dysfunction and Chronic Disease: Treatment With Natural Supplements.The Hidden Treasure of Neonatal Screening: Identifying New Risk Factors and Possible Mechanisms of Necrotizing Enterocolitis Through Big Data.What Is Lipotoxicity?Metabolomic profiles of arsenic (+3 oxidation state) methyltransferase knockout mice: effect of sex and arsenic exposure.Effects of four different antihypertensive drugs on plasma metabolomic profiles in patients with essential hypertension.Angiocrine Wnt signaling controls liver growth and metabolic maturation in mice.Emerging Biomarkers of Illness Severity: Urinary Metabolites Associated with Sepsis and Necrotizing Methicillin-Resistant Staphylococcus aureus Pneumonia.Septic Shock Non-Survivors have Persistently Elevated Acylcarnitines Following Carnitine Supplementation.Associations between fatty acid oxidation, hepatic mitochondrial function, and plasma acylcarnitine levels in mice.Elevated Medium Chain-Acylcarnitines are Associated with Gestational Diabetes, and Early Progression to Type-2 Diabetes, and Induce Pancreatic β-Cell Dysfunction.Interventional Left Atrial Appendage Closure Affects the Metabolism of Acylcarnitines.
P2860
Q28073319-C2284622-0E5E-4551-BA6F-4CF53083A4E7Q28080686-340883FB-A17E-4C8A-A95C-2B0C70686BC3Q28551938-1C95D9AD-1160-4C5E-84D6-200C7C41F8DDQ33591146-374910C6-8179-49EB-A5AE-5FA894DA1415Q33625700-C4FA3326-63D7-4EEB-9560-CCD4288FB2D1Q33810793-C8072768-E6C5-4156-AFE5-BE5CC955583DQ33838799-574B0C11-33C4-4A75-8A29-62BD38F0921EQ34285719-AE9EC2E0-2106-4889-94BF-69798205BE15Q34499637-CB4C6918-4A41-46AF-A18F-9C79CCF48FFFQ34796255-CE4CAE2D-5503-467C-9AB8-2DEB627EC9C4Q35128445-592F3D29-C07D-476B-91F2-C4910FF304B0Q35218032-C0AF37B8-1D9C-43AB-A539-8DE3DB02C433Q35220712-BB606D84-D15F-48C7-BFEC-BFBF249E4803Q35836537-0842C923-A90D-4282-9821-8C8D0B3360DCQ36093092-A86E2D60-DF34-485D-9B09-09F4220C8E2FQ36370184-39D183A3-254D-43BE-BB2B-5EFC51520B2BQ36828661-6AFC6A69-FCE4-48B4-8F49-75FF2F86546EQ36867088-7AA950E9-3060-4D97-9CE9-FA4CFA005356Q36937651-C2DA16A9-0A2F-419E-9899-F923706838D1Q37137602-CB4D8106-FC31-43A9-8411-432E0CAE2E29Q37240351-C53C4992-ECAC-4621-8A4F-1D7DF0C5EF65Q37593632-AF031FCD-165F-470E-B120-FC5F28BF5FAAQ37714258-3CAF8190-FAA5-4BC0-93FC-4838C584C96AQ38381282-81E8CD08-5D6B-44B6-86DF-CCE6042E4B71Q38762944-35B362F0-2127-4834-8B55-14E643B8FA4FQ38962297-D334A08C-C457-49CA-9C96-BC8ADDA6F69EQ41857235-8F86A0D9-8EC2-4330-AEC7-F99E08375378Q41864413-0B6FFC37-47A0-487F-8053-40EF02D37F43Q42646705-D0CCE6BE-C541-430D-9E81-4FA9B8EE928DQ43198180-B082F5C9-F8DF-4E88-8953-4103ABC16102Q44353433-88F1FCE8-4912-4D5F-9454-1AE3C12A1510Q46355683-6CE1A94E-28F8-4CC4-AD0A-69A6F83A33B2Q47099590-8E08C7F2-4CFF-4D83-BBA4-F0B460F61B8CQ47168939-6F2BCC77-0794-4565-9CFC-B0588CDF8EA1Q47615942-680211A1-D408-43FC-9251-52EDED41DE8EQ48249825-D7D0E8FD-ED3F-4C42-9398-C2C63108C1BAQ49561103-D3E91CA9-83EB-49C5-8AB1-F6154B2325EAQ49785252-2813FC45-91F0-4501-931C-2E35E91B2CE0Q50048688-C715A425-758B-4B61-B831-F57BE22DD157Q50133651-DACBDC73-E910-42D9-8B20-2EF2A1E5E14A
P2860
Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.
@en
type
label
Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.
@en
prefLabel
Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.
@en
P2860
P1476
Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.
@en
P2093
Allan M Evans
Stephanie E Reuter
P2860
P304
P356
10.2165/11633940-000000000-00000
P577
2012-09-01T00:00:00Z